GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Naturalendo Tech Co Ltd (XKRX:168330) » Definitions » Cyclically Adjusted Revenue per Share

Naturalendo Tech Co (XKRX:168330) Cyclically Adjusted Revenue per Share : ₩786.89 (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Naturalendo Tech Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Naturalendo Tech Co's adjusted revenue per share for the three months ended in Dec. 2024 was ₩153.617. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩786.89 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Naturalendo Tech Co's average Cyclically Adjusted Revenue Growth Rate was -42.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2025-05-20), Naturalendo Tech Co's current stock price is ₩2205.00. Naturalendo Tech Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was ₩786.89. Naturalendo Tech Co's Cyclically Adjusted PS Ratio of today is 2.80.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Naturalendo Tech Co was 2.91. The lowest was 1.33. And the median was 1.73.


Naturalendo Tech Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Naturalendo Tech Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Naturalendo Tech Co Cyclically Adjusted Revenue per Share Chart

Naturalendo Tech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1,565.32 1,376.97 786.89

Naturalendo Tech Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,376.97 1,251.73 1,156.69 946.31 786.89

Competitive Comparison of Naturalendo Tech Co's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Naturalendo Tech Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Naturalendo Tech Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Naturalendo Tech Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Naturalendo Tech Co's Cyclically Adjusted PS Ratio falls into.


;
;

Naturalendo Tech Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Naturalendo Tech Co's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=153.617/121.1352*121.1352
=153.617

Current CPI (Dec. 2024) = 121.1352.

Naturalendo Tech Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 1,882.956 99.721 2,287.311
201506 350.473 100.051 424.331
201509 25.815 100.111 31.236
201512 24.280 100.220 29.347
201603 73.786 100.561 88.882
201606 119.349 100.791 143.439
201609 47.940 101.461 57.236
201612 99.369 101.561 118.520
201703 90.546 102.851 106.643
201706 107.392 102.611 126.779
201709 175.384 103.491 205.286
201712 101.086 102.991 118.895
201803 79.369 104.101 92.356
201806 130.108 104.130 151.355
201809 131.130 105.651 150.349
201812 98.637 104.351 114.502
201903 86.248 104.491 99.986
201906 90.890 104.881 104.976
201909 98.529 105.200 113.453
201912 45.641 105.121 52.594
202003 132.336 105.354 152.159
202006 135.588 105.112 156.257
202009 159.749 106.198 182.219
202012 241.208 105.765 276.260
202103 244.335 107.357 275.692
202106 215.440 107.579 242.589
202109 94.390 108.759 105.131
202112 58.038 109.676 64.102
202203 84.546 111.848 91.566
202206 117.164 114.072 124.418
202209 85.633 114.715 90.425
202212 154.381 115.179 162.364
202303 116.634 116.507 121.267
202306 138.601 117.182 143.277
202309 132.715 118.964 135.138
202312 210.624 118.837 214.697
202403 167.047 120.123 168.454
202406 183.316 120.007 185.039
202409 206.304 120.861 206.772
202412 153.617 121.135 153.617

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Naturalendo Tech Co  (XKRX:168330) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Naturalendo Tech Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2205.00/786.89
=2.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Naturalendo Tech Co was 2.91. The lowest was 1.33. And the median was 1.73.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Naturalendo Tech Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Naturalendo Tech Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Naturalendo Tech Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
E-201 Inno-Valley, Sampyung-dong, Bundang-gu, Kyunggi-do, Seongnam, KOR, 463-400
Naturalendo Tech Co Ltd is biotechnology company. It develops, manufactures, and sells health care products such as natural medicine, health food, cosmetic material, and transdermal drug delivery system.

Naturalendo Tech Co Headlines

No Headlines